... and
Intermittent Treatment
-3 0
-2 5
-2 0
-1 5
-1 0
-5
0
0
4
wk
8
wk
12
wk
16
wk
20
wk
24
wk
28
wk
32
wk
36
wk
lb.
Placebo
Q O Mo.
Continued
Munro JF et al. Br Med J 19 68 Feb 10;1(5 588 ):352
-4
Fig. 3. Intermittent ... National Institute of Child Health and Human Development
(NICHD) conference, the diagnosis of PCOS requires 1) oligo- or anovulation...
... and the development of diabetes. JAMA 2001; 286 : 188 2– 188 5.
44. Bosch J, Yusuf S, Gerstein HC, et al. Effect of ramipril on the incidence of diabetes. N Engl J Med 2006;355:1551–1562.
45. Dahlof ... DM Sanders L, Huang J. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 2003; 289 (14): 183 7– 185 0.
65. Foster, GD, Wyatt HR, Hill JO, et al. A randomized...
... effectiveness of both agents (85 ,86 ), and are thought to improve compliance and reduce the cost of treatment.
The effect of sulfonylureas on lipid profile components is slightly positive or neutral (82 ,87 ). ... C-reactive protein, soluble CD40 ligand, and plasma
monocyte chemoattractant protein-1 (MCP-1) (46,47,57, 58) , and 5) enhance fibrinolysis by decreasing plasma
plasm...
... 2 58 Goff and Cushman
over either monotherapy (79), a trial of the combination of trandolapril and verapamil showed no benefit of adding
verapamil to trandolapril or even of verapamil ... Outcome
Relative
Risk
Reduction
SHEP
88
583 5 yr 155/72* 146/ 68* Chlorthalidone Stroke 22% (ns)
CVD events 34%
CHD 56%
Syst-Eur
89
492 2 yr 162 /82 153/ 78 Nitrendipine Stroke CV events 6...
... Drug-Eluting Stents for In-Stent Restenosis
REALITY Prospective, Randomized, Multi-Center Comparison of the Cypher Sirolimus-Eluting and the Taxus Paclitaxel-Eluting Stent Systems
312 Petersen and ... wound-healing techniques, and treatment of
infection (unloading of the foot and administration of antibiotics). Surgical drainage and debridement are often
required to resolve...
... insulin-like growth factor-1 (IGF-1) may also be effective
in lowering glucose and HbA1c levels in CGL patients (81 ).
DIABETES OWING TO GENETIC DISORDERS OF -CELL FUNCTION
Maturity-Onset Diabetes of ... Endocrinol Metab 2004 ;89 : 383 5– 384 0.
92. Ortega-Gonzalez C, Luna S, Hernandez L, et al. Responses of serum androgen and insulin resistance to metformin and pioglitazone
in...